You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Kanamycin sulfate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for kanamycin sulfate and what is the scope of freedom to operate?

Kanamycin sulfate is the generic ingredient in four branded drugs marketed by Apothecon, Hikma, Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Loch, Pharmafair, Solopak, Warner Chilcott, Watson Labs, and King Pharms, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for kanamycin sulfate.

Summary for kanamycin sulfate
Medical Subject Heading (MeSH) Categories for kanamycin sulfate

US Patents and Regulatory Information for kanamycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loch KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 063025-001 Jul 31, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Loch KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 063022-001 Jul 31, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 062564-002 Sep 21, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Warner Chilcott KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 063092-001 Oct 11, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abraxis Pharm KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062504-002 Apr 5, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 061901-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 061901-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.